PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV

NIH RePORTER · NIH · N01 · $291,405 · view on reporter.nih.gov ↗

Abstract

PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

Key facts

NIH application ID: 10598444
Project number: 75N91019D00012-P00003-759102000001-1
Recipient: IIT RESEARCH INSTITUTE
Principal Investigator: DAVID MCCORMICK
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $291,405
Award type: —
Project period: 2020-09-08 → 2023-03-31